Refer A Patient

Request An Appointment

GastroenterologyRheumatology

CIMZIA

CIMZIA (certolizumab pegol) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells.
Infusion or injection therapy referral
What it treats Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Plaque Psoriasis, Non-Radiographic Axial Spondyloarthritis
Prescribed by Rheumatologists, Gastroenterologists & Dermatologists
How it’s administered Subcutaneous injection
Frequency Initial dose, then two weeks later, then four weeks later, and lastly every four weeks after
Length of treatment About 15 minutes

About This Therapy

CIMZIA (certolizumab pegol) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, helping to protect healthy cells from damage. Specifically, it is a tumor necrosis factor blocker (TNF) for treatment of Crohn’s disease, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

CIMZIA REFERRAL FORM

CIMZIA REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for CIMZIA

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.